1Regan J,Montriro F,Speiser D,et al.Pretransplant rejection risk assessment through enzyme linded immunosorbent assay analysis of anti-HLA Class Ⅰ antibodies[J].Am J Kidney Dis,1996,28(1):92-98.
2Jordan SC,Quartel AW,Czer LS,et al.Posttransplant therapy using high dose human immunoglobulin to control acute humoral rejection in renal and cardial allograft recipients and potential mechanism of action[J].Transplantation,1998,64 (6):800 -805.
5Hickstein H,Korten G,Bast R,et al.Immunoadsorption of sensitized kidney transplant candidates immediately perior to surgery[J].Clin Transplant,2002,16(2):97-101.
二级参考文献14
1Saito T,Sato H,Oikawa S.Lipoprotein glomerulopathy:A new aspect of lipid induced glomerular injury.Nephrology,1995,1:17-24.
2Saito T,Oikawa S,Sato H,et al.Lipoprotein glomerulopathy:Renal lipidosis induced by novel apolipoprotein E variants.Nephron,1999,83:193-201.
3Ieiri N,Hotta O,Taguma Y.Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.Am J Kidney Dis,2003,41 (1):244-249.
4Arai T,Yamashita S,Yamane M,et al.Disappearance of intraglomerular lipoprotein thrombi and narded improvement of nephritic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.Atherosclerosis,2003,169 (2):293-299.
5Li LS,Ji DX,Chen HP,et al.Immunoadsorption alone can effectively control lipoprotein glomerulopathy through the elimination of glomerular thrombi:Follow up study of cases.J Am Soc Nephrol,2004,15:A237.
6Giorstrup P,Watt RM.Therapeutic protein A immunoadsorption.A review Transfus Sci,1990,11:281-302.
7Deodhar A,Allen E,Daoud K,et al.Vasculitis secondary to staphylococcal protein A immunoadsorption (Prosorba column) treatment in rheumatoid arthritis.Semin Arthritis Rheum,2002,32:3 -9.
8Furst D,Felson D,Thoren G,et al.Immunoadsorption for the treatment of rheumatoid arthritis:final results of a randomized trial.Prosorba Trial Investigators.Ther Apheresis,2000,4:363-373.
9Balint JP,Cochran SK,Jones FR.Modulation of idiotypic and antiidiotypic immunoglobulin G responses in an immune thrombocytopenic purpura patient as a consequence of extracorporeal protein A immunoadsorption.Artif Organs,1995,19:496-499.
10Oikawa S,Suzuki N,Sakuma E,et al.Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.Am J Kidney Dis,1991,18:553 -558.
7Lorranine C,Kim S,Robert B,et al.The Banff 97 working classification of renal allograft pathology.Kidney Inter.1999;55:713-723.
8Sumitarr Holgersson S.HLA-spcific alloantibodies and renal graft outcom.Nephrol Dial Transplant.2001;16:897-904.
9Terasaki PL,Cho Y,Takemoto S,et al.Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival Transplant Proc.1996; 28(3):1144-1145.
10Chang G Mahanty H,Vincenti F,et al.A calcineurin inhibitor-sparing regimen withsirolimus,mycophenolate mofetil,and anti-cd25 mab provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft fanction.Clin Transplant.2000;14(6):550-560.
